SAN FRANCISCO, Jan. 23, 2019 /PRNewswire/ -- The One Health Company, a Silicon Valley-based startup whose
"At One Health, we're committed to advancing veterinary medicine and helping our beloved dogs live longer, healthier and happier lives," said One Health founder and CEO Christina Lopes. "By using the same diagnostics, machine learning rules, and drugs that are currently on the market for people, we're able to provide pet parents with cutting-edge cancer treatments at an affordable cost."
More than 90 million dogs are living in U.S. households, and an estimated one out of five of them will develop cancer at some point in their lives. One Health is the first company to bring next-generation sequencing to veterinary cancer. FidoCure, One Health's flagship product, allows users to purchase treatment plans for a fixed price and have access to the world's leading canine cancer care.
How FidoCure works:
"Advances in our understanding of cancer biology have revolutionized how we diagnose and treat human cancers," said Jorge Conde, general partner at Andreessen Horowitz. "As research continues to uncover similarities between certain dog and human cancers, One Health not only will harness these advances to transform how we care for our pets, but also has a unique opportunity to impact human health as it discovers better ways to manage this devastating disease in dogs."
About The One Health CompanyThe One Health Company is the first to bring the latest advances in human oncology to dogs with cancer. We deliver the most sophisticated diagnostics and create a tailored treatment for each dog. Visit theonehealthcompany.com.
View original content:http://www.prnewswire.com/news-releases/one-health-raises-5m-to-make-dog-cancer-treatment-more-accessible-and-affordable-300782813.html
SOURCE The One Health Company
Subscribe to our Free Newsletters!